Literature DB >> 16519710

Thalidomide for the treatment of leptomeningeal multiple myeloma.

Hattori Yutaka, Yabe Mariko, Okamoto Shinichiro, Morita Kunihiko, Tanigawara Yusuke, Ikeda Yasuo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16519710     DOI： 10.1111/j.1600-0609.2005.00591.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN： 0902-4441            Impact factor:   2.997


× No keyword cloud information.
  8 in total

1.  Meningeal myelomatosis developed after treatment with novel agents.

Authors:  Mikiko Ise; Chikara Sakai; Kyoya Kumagai
Journal:  Int J Hematol       Date:  2013-08-17       Impact factor: 2.490

Review 2.  Advances in the treatment of extramedullary disease in multiple myeloma.

Authors:  Yating Li; Zhengxu Sun; Xiaoyan Qu
Journal:  Transl Oncol       Date:  2022-06-06       Impact factor: 4.803

3.  Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice.

Authors:  Artur Jurczyszyn; Norbert Grzasko; Alessandro Gozzetti; Jacek Czepiel; Alfonso Cerase; Vania Hungria; Edvan Crusoe; Ana Luiza Miranda Silva Dias; Ravi Vij; Mark A Fiala; Jo Caers; Leo Rasche; Ajay K Nooka; Sagar Lonial; David H Vesole; Sandhya Philip; Shane Gangatharan; Agnieszka Druzd-Sitek; Jan Walewski; Alessandro Corso; Federica Cocito; Marie-Christine M Vekemans; Erden Atilla; Meral Beksac; Xavier Leleu; Julio Davila; Ashraf Badros; Ekta Aneja; Niels Abildgaard; Efstathios Kastritis; Dorotea Fantl; Natalia Schutz; Tomas Pika; Aleksandra Butrym; Magdalena Olszewska-Szopa; Lidia Usnarska-Zubkiewicz; Saad Z Usmani; Hareth Nahi; Chor S Chim; Chaim Shustik; Krzysztof Madry; Suzanne Lentzsch; Alina Swiderska; Grzegorz Helbig; Renata Guzicka-Kazimierczak; Nikoletta Lendvai; Anders Waage; Kristian T Andersen; Hirokazu Murakami; Sonja Zweegman; Jorge J Castillo
Journal:  Am J Hematol       Date:  2016-04-24       Impact factor: 10.047

4.  Central neurotoxicity of immunomodulatory drugs in multiple myeloma.

Authors:  Urmeel H Patel; Muhammad A Mir; Jeffrey K Sivik; Divisha Raheja; Manoj K Pandey; Giampaolo Talamo
Journal:  Hematol Rep       Date:  2015-03-03

Review 5.  Multiple Myeloma with Central Nervous System Relapse Early after Autologous Stem Cell Transplantation: A Case Report and Literature Review.

Authors:  Masaaki Hotta; Tomoki Ito; Akiko Konishi; Hideaki Yoshimura; Takahisa Nakanishi; Shinya Fujita; Atsushi Satake; Shosaku Nomura
Journal:  Intern Med       Date:  2021-02-01       Impact factor: 1.271

6.  Secondary CNS myeloma with remission after systemic CNS-penetrating agents.

Authors:  Luis G Fernandez; Daniel Eduardo Oyon; Vinai Gondi; Sean Grimm; Osaama H Khan
Journal:  Neurooncol Adv       Date:  2022-07-01

Review 7.  Central Nervous System Myeloma and Unusual Extramedullary Localizations: Real Life Practical Guidance.

Authors:  Vincenzo Sammartano; Alfonso Cerase; Valentina Venanzi; Maria Antonietta Mazzei; Beatrice Esposito Vangone; Francesco Gentili; Ivano Chiarotti; Monica Bocchia; Alessandro Gozzetti
Journal:  Front Oncol       Date:  2022-07-07       Impact factor: 5.738

Review 8.  Multiple myeloma with central nervous system relapse.

Authors:  Philip A Egan; Patrick T Elder; W Ian Deighan; Sheila J M O'Connor; H Denis Alexander
Journal:  Haematologica       Date:  2020-05-15       Impact factor: 9.941
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.